Pathologic Correlates of Dementia in Parkinson's Disease
Arch Neurol 43:991-995, Chui,H.C.,et al, 1986
Neuropeptides in Neurological Disease
Ann Neurol 20:547-565, Beal,M.F.&Martin,J.B., 1986
Alzheimer's Disease, Parkinson's Disease, & Motoneurone Disease:Abiotropic Interaction Between Ageing & Environment
Lancet 2:1067-1068, Calne,D.B.,et al, 1986
MR Imaging in"Lacunar"Hemiballismus
J Comput Assist Tomogr 10:793-797, Biller,J.,et al, 1986
Metoclopramide-Induced Parkinsonism in Hemodialysis Patients
Arch Int Med 146:2070-2071, Sirota,R.A.,et al, 1986
Locus Ceruleus Lesions & Eosinophilic Inclusions in MPTP-Treated Monkeys
Ann Neurol 20:449-455, Forno,L.S.,et al, 1986
Levodopa in Restless Legs
Lancet 2:426-427, vonScheele,C., 1986
Clinicopath. Conference
Pick's Disease of Brain, with Frontal Lobar Atrophy, Degen of Basal Ganglia, Case 16-1986, NEJM 314:, 101-,1986., 1986
The Clinical Features & Natural History of the Steele-Richardson-Olszewski Syndrome (Prog Supranuclear Palsy)
Neurol 36:1005-1006, Maher,E.R.,et al, 1986
Akathisia-Or not Sitting
BMJ 292:1034-1035, Szabadi,E., 1986
Is Multiple Sclerosis Caused by an Oral Spirochaete
Lancet 2:75-77, Gay,D.&Dick,G., 1986
MPTP:A Neurotoxin Relevant to the Pathophysiology of Parkinson's Disease, The 1985 George Cotzias Lecture
Neurol 36:250-258, Snyder,S.H.&D'Amato,R.J., 1986
Parkinsonism, Tardive Dyskinesia, Akathisia, & Depression Induced by Flunarizine
Lancet 1:1303-1304, Chouza,C.,et al, 1986
Subcortical Dementia
BMJ 292:1035-1036, Foster,J.B., 1986
Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986
Narcolepsy & Immunity
BMJ 292:359-360, Parkes,J.D.,et al, 1986
Neural Transplantation:Scientific Gains & Clinical Perspectives
Neurol 36:389-392, Fishman,P.S., 1986
Infections with Herpes Simplex Viruses
NEJM 314:686-691, 749-7571986., Corey,L.&Spear,P.G., 1986
Amyotrophic Lateral Sclerosis, Associated Clinical Disorders & Immunological Evaluations
Arch Neurol 43:234-238, Appel,S.H.,et al, 1986
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Paraquat & Parkinson's Disease
Neurol 36:1147, Koller,W.C., 1986
Disappearance of Parkinsonian Signs after Spontaneous Vascular"Thalamotomy"
Arch Neurol 43:815-817, Dubois,B.,et al, 1986
Parkinson's Disease
BMJ 293:379-382, Quinn,N.P.&Husain,F.A., 1986
Magnetic Resonance Imaging of the Midbrain in Parkinson's Disease
Ann Neurol 20:744-747, Duguid,J.R.,et al, 1986
Initiation of Levodopa Therapy in Parkinsonisn Patients Should be Delayed Until the Advanced Stages of the Disease
Arch Neurol 43:402-407, Melamen,E., 1986
Modification of Parkinson's Disease by Long-Term Levodopa Treatment
Arch Neurol 43:405-407, Markham,C.H.&Diamond,S.G., 1986
Pharmacologic Treatment of Parkinsonian Tremor
Arch Neurol 43:126-127, Koller,W.C., 1986
Painful Parkinson's Disease
Lancet 1:1366-1369, Quinn,N.P.,et al, 1986
Lithium for Painful Dystonia in Parkinson's Disease
Lancet 1:1377, Quinn,N.&Marsden,C.D., 1986
Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986
Parkinson's Disease in Patients with Alzheimer's Disease
Arch Neurol 43:662-664, Leverenz,J.&Sumi,S.M., 1986
On Heredity, Twins, & Parkinson's Disease
Ann Neurol 19:409-411, Duvoisin,R.C., 1986
Parkinson's Disease in Monozygotic Twins
Ann Neurol 19:405-408, Jankovic,J.&Reches,A., 1986
Monozygotic Twins with Parkinson's Disease
Ann Neurol 19:402-405, Koller,W.,et al, 1986
Vascular Parkinsonism & Periarteritis Nodosa
Neurol 36:874-875, Mayo,J.,et al, 1986
Autonomic Dysfunction in Parkinson's Disease
Neurol 36:73-75, Goetz,C.G.,et al, 1986
Lisuride Infusion Pump:A Device for the Treatment of Motor Fluctuations in Parkinson's Disease
Lancet 1:467-470, Obeso,J.A.,et al, 1986
Swallowing & Speech Production in Parkinson's Disease
Ann Neurol 19:238-287, Robbins,J.,et al, 1986
Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986
Fetal Neuronal Grafts in Monkeys Given Methylphenyltetrahydropyridine
Lancet 1:1125-1127, Redmond,D.E.,et al, 1986
Parkinsonism Following Dystonia in Three Patients
Movement Disorders 1:151-157, Katchen,M.&Duvoisin,R.C., 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
Dystonia in Untreated Parkinsonism
Clin Neuropharmacol 9:293-297, LeWitt,P.A.,et al, 1986
A Neuroleptic Malignantlike Syndrome Due to Levodopa Therapy Withdrawal
JAMA 254:2792-2795, Friedman,J.H.,et al, 1985
Cerebral Lateralization, Biological Mechanisms, Associations, & Pathology:I
Arch Neurol 42:428-459, 4271985., Geschwind,N.&Galaburda,A.M., 1985
Cerebral Lateralizaion, Biological Mechanisms, Associations, & Pathology:III
Arch Neurol 42:634-654, Geschwind,N.&Galaburda,A.M., 1985
Atypical Presentation of Progressive Supranuclear Palsy
Ann Neurol 17:334-343, Davis,P.H.,et al, 1985
Treatment of Progressive Supranuclear Palsy with Tricyclic Antidepressants
Neurol 35:1189-1193, Newman,G.C., 1985
The Clinical Syndrome of Striatal Dopamine Deficiency, Parkinsonism Induced by MPTP
NEJM 312:1418-1421, Burns,R.S.,et al, 1985
Permanent Human Parkinsonism Due to 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP) :Seven Cases
Neurol 35:949-956, Ballard,P.A.,et al, 1985